Can a patient registry unlock the secrets of a rare cancer?
NCT ID NCT05438537
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study follows 300 men with upper tract urothelial cancer (UTUC), a rare cancer of the kidney's drainage system, to track their long-term survival, recurrence, and complication rates. By prospectively collecting data from patients before and after surgery or other interventions, researchers aim to better understand the physical and biological effects of the disease. The goal is to fill gaps in knowledge and potentially improve future management and follow-up strategies for UTUC.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This registry could improve understanding of upper tract urothelial cancer, potentially guiding better management strategies and follow-up care.
- What could go wrong
- As an observational registry, it cannot prove cause and effect. Findings may be limited by single-center data and may not apply to broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER TRACT UROTHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prince of Wales Hospital
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.